Endothelin-1-mediated cerebrovascular remodeling is not associated with increased ischemic brain injury in diabetes.
Endothelin-1-mediated cerebrovascular remodeling is not associated with increased ischemic brain injury in diabetes. Can J Physiol Pharmacol. 2010 Aug; 88(8):788-95.